Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Link

Showing results (131-140 of 328) with videos related to

Pageof 33
Sort By:
Nuclear Medicine Communications|July 22, 2004
99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphomaDavid L Bushnell, Yusuf Menda, Mark T Madsen, et al.
Leukemia & Lymphoma|February 10, 2010
18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reportsAlexandra Thomas, Roger D Gingrich, Brian J Smith, et al.
Clinical Endocrinology|December 16, 2017
High risk of hypogonadism in young male cancer survivorsS Isaksson, K Bogefors, O Ståhl, et al.
The American Journal of Physiology|October 11, 1988
Impact of sex steroids and their suppression on skeletal growth and maturationP A Boepple, M J Mansfield, K Link, et al.
Cancer|December 18, 2001
Delivering adjuvant chemotherapy to women with early-stage breast carcinoma: current patterns of careB K Link, G T Budd, S Scott, et al.
The Lancet. Oncology|March 24, 2020
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trialMadeleine T King, Emma K Link, Tim J Whelan, et al.
American Journal of Hematology|April 29, 2016
Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United StatesChadi Nabhan, Xiaolei Zhou, Bann-Mo Day, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphomaJ M Vose, B K Link, M L Grossbard, et al.
Bone Marrow Transplantation|August 4, 2012
Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cellsK E Herbert, P Gambell, E K Link, et al.
Pharmacotherapy|May 19, 2005
Effect of clinical characteristics on neutropenia-related inpatient costs among newly diagnosed non-Hodgkin's lymphoma cases during first-course chemotherapyElizabeth A Chrischilles, Donald G Klepser, John M Brooks, et al.
Pageof 33

Showing results (131-140 of 328) with videos related to

Sort By:
Pageof 33
Nuclear Medicine Communications|July 22, 2004
99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphomaDavid L Bushnell, Yusuf Menda, Mark T Madsen, et al.
Leukemia & Lymphoma|February 10, 2010
18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reportsAlexandra Thomas, Roger D Gingrich, Brian J Smith, et al.
Clinical Endocrinology|December 16, 2017
High risk of hypogonadism in young male cancer survivorsS Isaksson, K Bogefors, O Ståhl, et al.
The American Journal of Physiology|October 11, 1988
Impact of sex steroids and their suppression on skeletal growth and maturationP A Boepple, M J Mansfield, K Link, et al.
Cancer|December 18, 2001
Delivering adjuvant chemotherapy to women with early-stage breast carcinoma: current patterns of careB K Link, G T Budd, S Scott, et al.
The Lancet. Oncology|March 24, 2020
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trialMadeleine T King, Emma K Link, Tim J Whelan, et al.
American Journal of Hematology|April 29, 2016
Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United StatesChadi Nabhan, Xiaolei Zhou, Bann-Mo Day, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphomaJ M Vose, B K Link, M L Grossbard, et al.
Bone Marrow Transplantation|August 4, 2012
Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cellsK E Herbert, P Gambell, E K Link, et al.
Pharmacotherapy|May 19, 2005
Effect of clinical characteristics on neutropenia-related inpatient costs among newly diagnosed non-Hodgkin's lymphoma cases during first-course chemotherapyElizabeth A Chrischilles, Donald G Klepser, John M Brooks, et al.
Pageof 33